ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OXN Oxonica

3.125
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxonica LSE:OXN London Ordinary Share GB00B0D09P49 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.125 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Oxonica Share Discussion Threads

Showing 251 to 271 of 375 messages
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
25/11/2007
14:48
Some sort of knak by M.M.s-they know all the tricks,never tell the punter[investor]until its too late.
mbugger
23/11/2007
15:54
Top % riser of the day- anyone know why?
mangal
22/11/2007
20:34
cootuk, as you wrote, 9 months operational cash. Seems like we need some serious business, in terms of revenue & cashflow - within the next 6 months or so. Or else.............

powwow, yes, people are here, but probably cannot be bothered to post, this has seemed fairly hopeless for a long time. In fact since the Turkish delight. Happen the Dragon's Den man (who is subscribing for a wedge of shares in this fundraising)- is getting things moving here. It has gone from (respectable) tipsters stuff, to a dog - in a matter of months. Though the fact that the VCT's & co are putting up more money, might suggest they know of impending contracts/revenue streams that we don't. I guess it is down to faith, until we get hard evidence. Time will tell. As usual.

damanko
22/11/2007
17:00
So enough cash for another 9 months but a large dilution for those who have already lost out on the share price anyway.
cootuk
22/11/2007
16:10
no one here ?
powwow
16/11/2007
04:48
No news of fundraising yet, or of Envirox in the US.
Last one out turn off the lights?

cootuk
29/9/2007
07:56
Take AIM: Dragon's Den helps Oxonica turn Turkey Published: 17:21 Friday 28 September 2007
By Douglas Bence, Companies Correspondent

Nanomaterials group Oxonica is involved with improving fuel combustion, providing ultra violet screening in sun care products and tagging objects used in security identification.

For those that may not know, nano is a Latin word meaning small, in a modern sense a one thousand millionth part.

It was being small, if not nano-sized that gave AIM-listed Oxonica the biggest problem in its history earlier this year, forcing its shares to be suspended and triggering a hunt for new capital.

One of its best known products is Envirox, a fuel catalyst that improves consumption and reduces emissions. It was tested by transport group Stagecoach in London before it sold that part of its bus operations to the Australian group Macquarie.

Oxonica's energy division had a contract with Petrol Ofisi, Turkey's leading oil company. Most of Turkey's fuel comes from Russia and tends to have a high, and environmentally undesirable, sulphur content that was hitting Petrol Ofisi's market share. It was thought that these disadvantages could be reduced by Envirox.

Tests were done and the benefits measured. But for a science-based company like Oxonica, which spun out of Oxford University in 1999, there were too many variables: different vehicles on sometimes dubious road surfaces with different drivers in a range of environments and weather conditions.

Although there was plenty of positive anecdotal evidence, Petrol Ofisi felt it insufficiently hard for it to promote the treated fuel as aggressively as planned. The results were dismissed as inconclusive and Oxonica fired.

The size of the deal and the initial uncertainties associated with its loss gave the board no option but to suspend the shares at 117.5p on 27 April. They had been pushed up to 150p when the Petrol Ofisi contract was landed in August 2006 and on 24 October peaked at 172.5p.

Oxonica clarified its position with Petrol Ofisi, tried to rebuild the trial programme and took drastic steps to reduce costs. But when the share suspension was lifted on 5 June, Oxonica's shares plunged to 34p and bottomed on 15 June at 30.5p.

'We did all the things you would expect as well as initiating a detailed strategic review of the business the conclusion of which was to raise additional funds,' chief executive Kevin Matthews told Citywire.

Although the discussions are now at an advanced stage to raise a currently undisclosed amount, but probably around £7 million, the story changes at this point.

Oxonica came to AIM in July 2005 with a private placing targeting individuals rather than City institutions.

The second largest shareholder with 16% is entrepreneur Richard Farleigh, a former potential investor in the reality TV programme Dragon's Den. He has become chairman of Oxonica and is masterminding the fundraising, again with individuals.

It is hoped that this will increase liquidity in the stock, which closed today 2p higher 36.5p with just 13 deals involving under 28,000 shares, and attract institutional interest.

Revenue in the six months to 30 June increased 142% to £3.1 million against £1.3 million last time. But £2.1 million of this against £300,000 comprised sales of Envirox to Petrol Ofisi.

Excluding these, Envirox revenue was slightly lower than in the first half of 2006 mainly due to the loss of the Stagecoach London depots following the sale to Macquarie.

As well as selling to the energy industry, Oxonica also deals with the healthcare, materials and security markets. The security business has a number of orders for delivery in the second half and a research and development agreement has been reached with the US company BD for diagnostic work.

Optisol is an ultra violet protection system designed for use in sunscreen creams and products to treat premature aging. Sales doubled to £265,000 in the half year against £108,000 last time. The product is now used in 27 formulations by 14 customers including Boots in nine countries.

Although gross profit increased 59% to £1.2 million against £800,000, the operating loss for the first half was £3.2 million against £2.9 million.

Citywire Verdict:
Definitely a company to watch, and a share worth acquiring for the medium to long term.

ariane
27/9/2007
14:55
That looks to me like OXN can't afford to do the funding so BD will take the lions share of the technology...if it succeeds.
cootuk
23/9/2007
15:40
Being a fairly new shareholder of this company, I was impressed when Richard Farleigh upped his interest. I think this a company of the future. Is it going to come good again? Any ideas.
jeaniehow
11/9/2007
06:05
Oxonica New distribution agreement


RNS Number:6241D
Oxonica plc
10 September 2007





11 September 2007


Oxonica plc


New supply and distribution agreement between Oxonica
Energy and Nyacol Nano Technologies Inc


Oxonica plc ("Oxonica"), a leading international nanomaterials group, today
announces the signing of a new agreement between its subsidiary Oxonica Energy
Limited ("Oxonica Energy") and Nyacol Nano Technologies, Inc ("Nyacol"). The
signing of this two part agreement establishes a strategic relationship between
the companies which secures the long term cost effective supply of Oxonica's
EnviroxTM diesel fuel catalyst and assigns the distribution rights in certain
Asian territories to Nyacol.


Dr Kevin Matthews, CEO of Oxonica, said "The relationship with Nyacol
establishes a strong supply position and also through Nyacol's extensive network
in Asia the potential to accelerate the uptake of EnviroxTM in the region''


Robert J Nehring Jr., CEO of Nyacol, said "This agreement allows Nyacol to
combine its key strengths of nanomaterial manufacturing and an Asian network
with Oxonica's application expertise to sell EnviroxTM diesel fuel catalyst into
a region where we believe there is the potential for significant growth. Our
relationship with Oxonica is developing all the time and I see the opportunity
for both companies to benefit greatly from the agreement."

For further information, please contact:


Oxonica plc 01865 856 700

Kevin Matthews, Chief Executive

Richard Clarke, Finance Director


The Broadcast PR Business 0207 812 6624

Matthew Locke



Notes to Editors

About Oxonica plc - www.oxonica.com

Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, healthcare,
materials and security.

The Group currently has four operating divisions: Oxonica Energy, Oxonica
Healthcare, Oxonica Materials and Oxonica Security. Oxonica has already
launched products into international markets. Lead products include:

* EnviroxTM Fuel Borne Catalyst - a nanocatalyst improving fuel economy
and reducing emissions
* OptisolTM UV Absorber - a revolutionary photostable UV protection system
designed to optimise the performance of quality sunscreens and
anti-premature aging products


Oxonica is also active in searching for the next generation of products and is
already engaged in developing transformational detection technologies which will
enable a new generation of ultrasensitive multiplex diagnostic tools for the
clinical diagnostic life science and security markets. In addition, the company
is developing other UV absorber technologies into polymer systems and coatings,
based on similar technologies to that used in OptisolTM.



About Nyacol Nano Technologies, Inc - www.nyacol.com


Nyacol Nano Technologies Inc. was founded in 1969 and is a privately held
corporation.

Nyacol has developed a variety of proprietary nano-particle technologies for
manufacturing specialized inorganic colloids. Its founders created a unique
process for manufacturing colloidal silica, or silica sol. These nano-particle
techniques have been expanded to metal oxides such as antimony pentoxide and the
oxides of aluminium, cerium, tin, yttrium and zirconium.

The special properties and adaptability of Nyacol's colloidal silica, and metal
oxides have earned a worldwide reputation for reliability, quality and
adaptability.



This information is provided by RNS
The company news service from the London Stock Exchange

END
AGRFGGMLLGMGNZM

ariane
26/8/2007
12:47
I could understand a general working party to influence 'decision makers' in the EU regulatory side and the EPA.
cootuk
26/8/2007
08:08
Hm.... excellent verse.
For now, then;

Always look on the bright side of life..

damanko
25/8/2007
19:52
I never heard such a pile of junk in all my life.

Nanotech code of conduct, LMAO.

What they infact mean is Nanotech is buzz word and they want to control who uses it... Nevermind what they ever might do in future like ever becoming profitable.


... It could almost be a Monty Python sketch..

"We are Oxford knights of the nanotech table..
We raise cash whenever we're able..
We laugh all night, deciding what nanotech's right..
(something else..).

This company needs focus..

officerdigby
15/8/2007
09:22
I assume one of the core codes of conduct for suppliers to the industry will that they must be solvent and have a sustainable business. It therefore beggars belief that Oxonica think they are the appropriate people to tell the industry what to do. I suggest they concentrate on the critical matter of revenue and cash generation and cost reduction rather than joining and academic-induced mutual back-slapping party! Or else, by the time any material conclusions are reached (if any) there will be no company left to benefit. IMHO the press release demonstrates just how far away are Oxonica's navel-gazing management from recognizing the criticial aspects on how to run a business.
bearfoot
09/8/2007
08:46
Oxonica NanoTech Code of Conduct


RNS Number:8012B
Oxonica plc
09 August 2007


PRESS RELEASE


Industry leaders to develop nanotech Code of Conduct

Oxford, UK, August 8 2007. Leading International nanomaterials group Oxonica is
joining forces with other industry experts in a new initiative to develop a Code
of Conduct for businesses working with nanotechnologies.

The aim of the voluntary Code will be to establish good practice for businesses
involved in all aspects of emerging nanotechnologies including research,
development, manufacturing, distribution and retailing.

Oxonica is a member of the Nanotechnology Industry Association, one of the four
founding partners responsible for developing the Code. A working party has been
formed with other groups including business and non-governmental organisations
along with scientists and social scientists. Confirmed members of the working
group so far include - amongst others - the chemical company BASF, Unilever,
Tesco, the consumer group Which? and development NGO Practical Action.

Kevin Matthews, CEO of Oxonica said "At Oxonica we are committed to developing
nanotechnology based products, responsibly in partnership with other leading
companies that address major global issues and market needs. In this rapidly
developing market we are pleased to be working with other industry leaders to
develop a Code that will set the standards for the nanotechnology community to
operate within".

The initiative to develop a Code of Conduct for businesses working with
nanotechnologies has been launched by the Royal Society, Insight Investment, the
Nanotechnology Industries Association and the Nanotechnology Knowledge Transfer
Network.

The Code will be voluntary with companies being encouraged to publicly explain
how they comply with its principles through, for example statements in annual or
corporate responsibility reports. The Code will set out expected corporate
behaviours and management processes rather than an auditable standard, although
indicators of compliance may be developed.

An open consultation will take place in Autumn 2007 when a draft code will be
available for comment. More information is available from
www.responsiblenanocode.org. The working group aims to publish the Code early in
2008.

Ends



Notes to Editors

About Oxonica plc - www.oxonica.com

Oxonica (AIM: OXN.L) is one of the leading International nanomaterials groups
with products already launched into international markets and is listed in
London on the AIM market. It was spun-out from Oxford University in 1999.
Oxonica's mission is to focus on the development of innovative commercial
solutions for international markets using its expertise in the design and
application of nanomaterials. It owns a portfolio of demand driven products that
offer substantial benefits to the target markets of energy, healthcare,
materials and security. The Group currently has four operating divisions:
Oxonica Energy, Oxonica Healthcare, Oxonica Materials and Oxonica Security.
Oxonica has already launched products into international markets.

For more information on Oxonica please contact:

Nicole Love, Ogilvy Public Relations Worldwide, tel: 0207 309 1103, email
Nicole.love@uk.ogilvypr.com



This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAKKLBBDVBXBBK

waldron
24/7/2007
18:51
Having bought at 60 and not sold out at 80 I feel pretty stupid as I am down 46% (only put in small amount so didnt bother with my usual 10% stop) Though I might ride it out for a few months see if Farleigh can do anything to remedy his investing reputation.

But things dont look good.

An expensive and overwight management team
no sustainable product
lack of information on what they plan to win orders and increase revenue / cut costs

I want to be an optimist but can anyone give me a reason to jump in at these levels and not face a complete whitewash

angry manc
22/7/2007
10:56
i think theres far to many on the board...more members on the board the more Big paychecks go to them
petersmith6
21/7/2007
14:03
Times today mentions farleigh joining the board- it mentions his perma-tan as well!
bluepill
19/7/2007
09:33
it looks like a mini coup today

i can't see that the chairman is a reason for poor sales

OXN has a lot of directors for a small company...

nod
12/7/2007
15:18
So it looks like the Petrol Ofisi trial may have been to see how well this 'Compund B' performed compared to Neuftec 'Compund A' as coating on high sulphur diesel in the real world.
cootuk
12/7/2007
14:20
Yo yo continues, though today's RNS looks to be positive. The main thrust:

"Neuftec has now confirmed that its granted European patent in the UK (EP(UK)
1299508) does not cover the Envirox(TM) formulation currently sold by Energy and that Energy's dealings with this Envirox(TM) would not infringe any claim of this patent.

The only issue that remains is a narrow technical argument by Neuftec that
because of the wording of the licence agreement royalties are due on this
Envirox(TM) formulation up to the date the licence agreement was terminated.
Energy's outside solicitors and counsel have advised Energy that it has a strong case on this specific point.

At 31 December 2006, Oxonica was carrying the Neuftec licence in the balance
sheet as an intangible fixed asset at a value of £148,000. This has been
written-off subsequent to the year-end. Legal costs are being expensed as
incurred. As mentioned above, Neuftec has now confirmed that
this granted European patent in the UK does not cover Product B, the EnviroxTM
formulation currently sold by Oxonica, and that Energy's dealings with Product B would not infringe any claim of this patent."

damanko
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock